You just read:

Windtree Therapeutics' AEROSURF® (lucinactant for inhalation) Phase 2a Data Presented at the 2016 International Congress of Union of European Neonatal and Perinatal Societies

News provided by

Windtree Therapeutics, Inc.

Nov 28, 2016, 16:05 ET